LongLLYJul 2026
Eli Lilly and Company
Oak Ridge highlights the leading weight-loss drugmaker as one of the strongest healthcare contributors across its growth strategies. The investment case extends beyond obesity…
LLY
2 published ideas on Eli Lilly and Company across 2 funds — 2 long and 0 short.
Each entry below comes from a hedge fund's own investor letter, not a 13F filing, so it carries the reasoning behind the position on Eli Lilly and Company: the full thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Oak Ridge highlights the leading weight-loss drugmaker as one of the strongest healthcare contributors across its growth strategies. The investment case extends beyond obesity…
The Fund added to Eli Lilly because it views the company as a compelling large-scale opportunity in the still-underpenetrated GLP-1 market. It expects GLP-1 drugs to become…